AUTL vs EQIX · rev $71.9M vs P/E 79, rev $5.07B
Autolus Therapeutics Ltd (AUTL) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
AUTL currently screens at market cap $614.8M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the AUTL and EQIX stock pages for the full models.
Not investment advice.